Respida Capital announced the addition of two seasoned dealmakers to its leadership team. Kyle Kruse will join as principal, while Kyle Kolakoski takes the role of vice president. Both come with deep finance backgrounds that should reinforce Respida’s investment sourcing and execution capabilities in the competitive private‑equity market.

Kruse arrives from Ten Coves Capital, where he helped launch the firm as a vice president and founding partner, and earlier cut his teeth as an analyst on Morgan Stanley’s M&A and corporate strategy team. Kolakoski leaves Stephens, where he served as a vice president in its technology investment‑banking group, after a stint as a senior associate on Kroll’s technology valuation advisory practice.

Managing member James Zubok said the hires signal Respida’s intent to scale its deal flow and deepen sector expertise, particularly in technology and healthcare transactions where both newcomers have proven track records. Adding talent with M&A, investment‑banking and valuation experience should enable the firm to compete more aggressively for mid‑market buyout opportunities.

With $1.2 billion already deployed across more than 30 portfolio companies, Respida’s expanded leadership team may accelerate its push into larger, cross‑border deals. Investors watching the mid‑market private‑equity space will likely view the appointments as a vote of confidence in the firm’s growth trajectory and its ability to deliver returns amid heightened competition.